Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

5.52
Delayed Data
As of 2:17pm ET
 +0.105 / +1.94%
Today’s Change
3.22
Today|||52-Week Range
11.23
+50.27%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M+44.65%
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M+44.65%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K+30.36%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K+30.36%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+59.59%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+59.59%
Lea Leiv
Chief Financial Officer
Buy12/21/201824,700$4.15$102.5K+31.31%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/27/201820,000$3.29$65.8K+64.44%
Lea Leiv
Chief Financial Officer
Buy6/06/201915,500$3.56$55.2K+58.19%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy6/14/201911,657$3.40$39.6K+60.06%
Page of 2